Success Stories: EB-1A Approved for Postdoctoral Fellow in Missouri in the Field of Molecular Biochemistry
Client’s Testimonial:
Thanks for the help. I definitely will recommend your firm.
On May 29, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Molecular Biochemistry (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Missouri
Approval Notice Date: May 29, 2015
Processing Time: 24 Days (11 Days after Premium Processing Requested)
In this case, the client that we had the opportunity to work with was a postdoctoral fellow from China in the field of molecular biochemistry. He had conducted his research in the highly specialized area of establishing and depicting cellular targets for future anti-cancer drug therapies and stem cell regeneration. His work had resulted in 15 peer-reviewed scientific articles, 2 book chapters, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 235 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 41 manuscripts for at least 6 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] has improved on this limitation by developing a new strategy to promote programmed cell death in leukemic cells with neither a loss of efficiency nor extreme side effects. His efforts can therefore be said to be of critical need to the American fight against deadly cancers like leukemia.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of molecular biochemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 24 days.